Share a link:
https://casecent.re/p/63685
Write a review
|
No reviews for this item
This product has not been used yet
Abstract
Ronald W Dollens recently retired from the positions of CEO (Chief Executive Officer) and President of Guidant Corp, an Indianapolis-based medical technology manufacturer. Dollens was appointed CEO and President of Guidant when the company was formed as a split-off of Eli Lilly and Co in 1994. During his 10 years of leadership at Guidant, the firm grew at an average of 18% per year, from just under $900 million in sales in 1994 to $3.7 billion in 2003. Today, Guidant employs more than 12,000 and is an industry leader in cardiovascular technology.
About
Abstract
Ronald W Dollens recently retired from the positions of CEO (Chief Executive Officer) and President of Guidant Corp, an Indianapolis-based medical technology manufacturer. Dollens was appointed CEO and President of Guidant when the company was formed as a split-off of Eli Lilly and Co in 1994. During his 10 years of leadership at Guidant, the firm grew at an average of 18% per year, from just under $900 million in sales in 1994 to $3.7 billion in 2003. Today, Guidant employs more than 12,000 and is an industry leader in cardiovascular technology.